Description
Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus
Article: Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus
€2.42
Related products
-
Article: Highlights in melanoma
€2.42 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€2.42 Add to cart -
Article: Highlights in squamous cell carcinoma of the head and neck
€2.42 Add to cart -
Article: Highlights in respiratory oncology
€2.42 Add to cart
